EP3496753
PD-1 ANTIBODY FORMULATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
17.7.2017EP published:
22.11.2023EP application number:
17838513.4
EPO information:
European Patent Register
Max expiry date:
16.7.2037
Title in English:
PD-1 ANTIBODY FORMULATIONLanguage of the patent:
English
Timeline
Today
17.7.2017EP application
22.11.2023EP Publication
Owner
Name:
Innovent Biologics (Suzhou) Co., Ltd.Address:
168 Dongping Street Suzhou Industrial Park, Suzhou, Jiangsu 215123, CN
Inventor
Name:
CAO, WeiAddress:
Suzhou Jiangsu 215123, CN
Name:
LI, JunfengAddress:
Suzhou Jiangsu 215123, CN
Name:
LIU, XiaolinAddress:
Suzhou Jiangsu 215123, CN
Priority
Number:
PCT/CN2016/094094Date:
9.8.2016Country:
WO
Classification
Categories:
A61K 39/395, C07K 16/28, A61P 35/00